Avid Bioservices, Inc. Contracts & Agreements

Agreement and Plan of Merger, dated as of November 6, 2024, by and among Space Finco, Inc., a Delaware corporation, Space Mergerco, Inc., a Delaware corporation, and Avid... (Filed With SEC on November 7, 2024)

Second Amendment to Avid Bioservices, Inc. Deferred Compensation Plan (Filed With SEC on August 29, 2024)

Indenture, dated as of March 12, 2024, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee (Filed With SEC on March 14, 2024)

Amendment No. 2 to Credit Agreement, dated as of March 12, 2024, by and among the Company, the lenders party thereto and Bank of America, N.A. as administrative Agent (Filed With SEC on March 14, 2024)

First Amendment to Avid Bioservices, Inc. Deferred Compensation Plan (Filed With SEC on November 14, 2023)

Amendment No. 1 to Credit Agreement, dated as of October 27, 2023, among Avid Bioservices, Inc., as the Borrower, the Lenders party hereto, and Bank of America, N.A., as... (Filed With SEC on November 2, 2023)

Avid Bioservices, Inc. Deferred Compensation Plan (Filed With SEC on July 13, 2023)

Form of Notice of Grant of Performance Stock Unit Award (Filed With SEC on July 13, 2023)

Description of Registrants Securities (Filed With SEC on June 21, 2023)

Executive Severance Plan adopted December 5, 2022 (Filed With SEC on December 9, 2022)

Form of Notice of Grant of Performance Stock Unit Award (Filed With SEC on July 14, 2022)

Description of Registrants Securities (Filed With SEC on June 29, 2022)

First Amendment to the Avid Bioservices, Inc. 2018 Omnibus Incentive Plan (Filed With SEC on December 7, 2021)

Form of Notice of Grant of Performance Stock Unit Award (Filed With SEC on July 14, 2021)

Description of Registrants Securities (Filed With SEC on June 29, 2021)

Agreement and Plan of Merger, dated as of April 30, 2021, by and between Avid SPV, LLC and Avid Bioservices, Inc (Filed With SEC on May 5, 2021)

First Supplemental Indenture, dated as of April 30, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association (Filed With SEC on May 5, 2021)

Form of Capped Call Transactions Confirmation (Filed With SEC on March 12, 2021)

Indenture, dated as of March 12, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association, as trustee relating to the 1.250% Exchangeable Senior... (Filed With SEC on March 12, 2021)

Underwriting Agreement, dated December 10, 2020, between Avid Bioservices, Inc. and RBC Capital Markets, LLC (Filed With SEC on December 14, 2020)

Employment Agreement by and between Avid Bioservices, Inc. and Nicholas S. Green, effective July 30, 2020 (Filed With SEC on September 1, 2020)

Description of Registrants Securities (Filed With SEC on June 30, 2020)

Promissory Note, dated April 17, 2020, by and between Avid Bioservices, Inc. and City National Bank (Filed With SEC on April 23, 2020)

Amendment to Rights Agreement dated September 23, 2019, between Avid Bioservices, Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent (Filed With SEC on September 23, 2019)

Employment Agreement by and between Avid Bioservices, Inc. and Daniel R. Hart, effective June 26, 2019 (Filed With SEC on June 27, 2019)

Separation Agreement and Release of Claims between Roger J. Lias, Ph.D. and Avid Bioservices, Inc. dated June 12, 2019 (Filed With SEC on June 27, 2019)

Asset Assignment and Purchase Agreement by and between Avid Bioservices, Inc. and Oncologie, Inc., dated February 12, 2018 (Filed With SEC on July 16, 2018)

Severance Agreement and Mutual General Release between Steven W. King and Avid Bioservices, Inc. dated December 22, 2017 (Filed With SEC on March 12, 2018)

Underwriting Agreement, dated February 14, 2018, between Avid Bioservices, Inc. and Wells Fargo Securities, LLC (Filed With SEC on February 16, 2018)

Settlement Agreement, dated November 27, 2017 by and among Peregrine Pharmaceuticals, Inc., Ronin Trading, LLC, Ronin Capital, LLC, SWIM Partners LP, SW Investment Management LLC,... (Filed With SEC on November 28, 2017)

AMENDED AND RESTATED RIGHTS AGREEMENT by and between PEREGRINE PHARMACEUTICALS, INC. and BROADRIDGE CORPORATE ISSUER SOLUTIONS, INC. as Rights Agent Amended and Restated as of... (Filed With SEC on March 17, 2016)

PeregrinePharmaceuticals, Inc. Common Stock Purchase Agreement 18,518,518Shares of Common Stock October 30,2015 (Filed With SEC on October 30, 2015)

PeregrinePharmaceuticals, Inc. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on August 7, 2015)

PEREGRINE PHARMACEUTICALS, INC. $20,000,000 COMMON STOCK EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on August 7, 2015)

FIRST AMENDMENT TO THE PEREGRINE PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (Filed With SEC on July 14, 2015)

FIRST AMENDMENT TO THE PEREGRINE PHARMACEUTICALS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on July 14, 2015)

THIRD AMENDMENT TO THE PEREGRINE PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on July 14, 2015)

FORM OF AMENDMENT TO NON-QUALIFIED STOCKOPTION AGREEMENT UNDER THE PEREGRINE PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (NON-EMPLOYEE DIRECTORS) (Filed With SEC on July 14, 2015)

FORM OF AMENDMENT TO NON-QUALIFIED STOCKOPTION AGREEMENT UNDER THE PEREGRINE PHARMACEUTICALS, INC. 2009 STOCK INCENTIVE PLAN (NON-EMPLOYEE DIRECTORS) (Filed With SEC on July 14, 2015)

FORM OF aMENDMENTTO STOCK OPTION AWARD AGREEMENT UNDER THE PEREGRINE PHARMACEUTICALS,INC. 2011 STOCK INCENTIVE PLAN (NON-EMPLOYEE DIRECTORS) (Filed With SEC on July 14, 2015)

Amendment No. 1 to At Market Issuance Sales Agreement (Filed With SEC on April 14, 2015)

PeregrinePharmaceuticals, Inc. 10.50%Series E Convertible Preferred Stock (liquidationpreference $25.00 per share) At Market Issuance Sales Agreement (Filed With SEC on June 16, 2014)

PeregrinePharmaceuticals, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 16, 2014)

PEREGRINEPHARMACEUTICALS, Inc. 700,000 Shares 10.50% Series E Convertible PreferredStock (Plus up an Option to Purchase upto 105,000 Shares to Cover Overallotments) UNDERWRITING... (Filed With SEC on February 12, 2014)

AMENDED ANDRESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2013)

EMPLOYMENTAGREEMENT (Filed With SEC on March 12, 2013)

AMENDED ANDRESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2013)

PeregrinePharmaceuticals, Inc. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 28, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 10, 2012)

CERTAINCONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[**]”. A COMPLETE VERSION OF THIS EXHIBIT HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on December 10, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 10, 2012)

EMPLOYMENTAGREEMENT (Filed With SEC on September 10, 2012)

LOANAND SECURITY AGREEMENT (Filed With SEC on July 16, 2012)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on September 2, 2011)

PEREGRINE PHARMACEUTICALS, INC. (Filed With SEC on September 2, 2011)

[Form of Restricted Stock Issuance Agreement dated February 1, 2010] PEREGRINE PHARMACEUTICALS, INC. [Plan Year] STOCK INCENTIVE PLAN STOCK ISSUANCE AGREEMENT (Filed With SEC on July 14, 2011)

ANNUAL BONUS PLAN FOR EXECUTIVE OFFICERS PEREGRINE PHARMACEUTICALS, INC. ADOPTED JULY 12, 2011 (Filed With SEC on July 14, 2011)

Peregrine Pharmaceuticals, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 29, 2010)

ASSIGNMENT AGREEMENT (Filed With SEC on September 9, 2010)

LICENSE AGREEMENT (Filed With SEC on September 9, 2010)

[Formof Restricted Stock Issuance Agreement dated February 1, 2010] PEREGRINEPHARMACEUTICALS, INC. (Filed With SEC on July 14, 2010)

Peregrine Pharmaceuticals, Inc. (Filed With SEC on June 22, 2010)

LICENSEAGREEMENT between LONZABIOLOGICS PLC and PEREGRINEPHARMACEUTICALS INC (Filed With SEC on April 14, 2010)

EXCLUSIVEPATENT LICENSE AGREEMENT (Filed With SEC on April 14, 2010)

AMENDMENTNo. 1 TO EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on April 14, 2010)

EXCLUSIVEPATENT LICENSE AGREEMENT (Filed With SEC on April 14, 2010)

AMENDMENTNo. 1 TO EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on April 14, 2010)

NON-EXCLUSIVECABILLY PATENT LICENSE AGREEMENT (Filed With SEC on April 14, 2010)

COMMERCIALLICENSE AGREEMENT (Filed With SEC on April 14, 2010)

LICENSEAGREEMENT (Filed With SEC on April 14, 2010)

PEREGRINEPHARMACEUTICALS, INC. 2009STOCK INCENTIVE PLAN NON-QUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on October 27, 2009)

PEREGRINEPHARMACEUTICALS, INC. 2009STOCK INCENTIVE PLAN INCENTIVESTOCK OPTION AGREEMENT (Filed With SEC on October 27, 2009)

AtMarket Issuance Sales Agreement (Filed With SEC on July 14, 2009)

EMPLOYMENTAGREEMENT (Filed With SEC on July 14, 2009)

AtMarket Issuance Sales Agreement (Filed With SEC on March 27, 2009)

INTELLECTUALPROPERTY SECURITY AGREEMENT (Filed With SEC on March 12, 2009)

LOANAND SECURITY AGREEMENT (Filed With SEC on March 12, 2009)

SECUREDTERM PROMISSORY NOTE $1,500,000 December 19, 2008 (Filed With SEC on March 12, 2009)

SECUREDTERM PROMISSORY NOTE $3,500,000 December 19, 2008 (Filed With SEC on March 12, 2009)

INTELLECTUALPROPERTY SECURITY AGREEMENT (Filed With SEC on March 12, 2009)

WARRANTTO PURCHASE STOCK Company: PEREGRINE PHARMACEUTICALS, INC., a Delaware corporation Number of Shares: 1,184,433, plus all Additional Shares which Holder is entitled to... (Filed With SEC on March 12, 2009)

WARRANTTO PURCHASE STOCK Company: PEREGRINE PHARMACEUTICALS, INC., a Delaware corporation Number of Shares: 507,614, plus all Additional Shares which Holder is entitled to... (Filed With SEC on March 12, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2007)

Address for notice: 1270 Avenue of the Americas, 16th Floor New York, NY, 10020 Accepted and Agreed to as of the date first written above: PEREGRINE PHARMACEUTICALS, INC. By: /s/... (Filed With SEC on June 28, 2007)

PEREGRINE PHARMACEUTICALS, INC. PERFORMANCE SHARE AWARD AGREEMENT/ STOCK BONUS PLAN (Filed With SEC on July 14, 2006)

PEREGRINE PHARMACEUTICALS, INC. and INTEGRITY STOCK TRANSFER, INC. as Rights Agent RIGHTS AGREEMENT Dated as of March 16, 2006 TABLE OF CONTENTS (Filed With SEC on March 17, 2006)

PEREGRINE PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on October 28, 2005)

PEREGRINE PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on October 28, 2005)

Category

Industry

Companies

Contracts

Avid Bioservices, Inc. Contracts & Agreements